Clinical Trials

Multiple Myeloma

NCT05887726 2023-07-27

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

30 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

Other hematologic neoplasm

Hematologic Neoplasms

NCT04304352 2023-06-28

VEX

162 enrolled

Advanced Breast Cancer

NCT05914753 2023-06-22

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

200 enrolled

Breast Neoplasms

NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05872412 2023-05-25

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

82 enrolled

Triple Negative Breast Neoplasms

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Recurrence, Lymphoma, B-Cell

NCT05798546 2023-04-04

Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

21 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05777369 2023-03-21

R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma

30 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05776407 2023-03-20

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Phase 1/2 Unknown

12 enrolled

Lymphoma, B-Cell

NCT03467256 2023-02-24

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Phase 1/2 Unknown

18 enrolled

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04688021 2023-02-21

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Other hematologic neoplasm

46 enrolled

Graft vs Host Disease, Leukemia

NCT05322330 2023-02-09

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Lymphoma, B-Cell

NCT04706936 2023-02-06

Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma

25 enrolled

Multiple Myeloma, Recurrence

NCT03252600 2023-01-25

Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

53 enrolled

Immunoglobulin Light-chain Amyloidosis

NCT05681728 2023-01-12

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

26 enrolled

Breast Neoplasms

NCT05665114 2023-01-03

Natural Killer(NK) Cell Therapy in r/r AML

Other hematologic neoplasm

18 enrolled

Leukemia, Myeloid, Acute

NCT05654077 2022-12-19

EBV CAR-T Cells for Nasopharyngeal Carcinoma

Phase EARLY_PHASE1 Unknown

24 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05656079 2022-12-19

easy laugh

204 enrolled

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

NCT05616468 2022-12-15

BGT007 Cell Treatment of Nasopharyngeal Carcinoma

23 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05580887 2022-10-14

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Unknown

35 enrolled

BreastGastrointestinal

Breast Neoplasms, Pancreatic Neoplasms

NCT01946373 2022-10-04

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Dermatologic

Melanoma

NCT03336073 2022-09-07

Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma

199 enrolled

Phase EARLY_PHASE1 Unknown

Multiple Myeloma

NCT05515185 2022-08-25

B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

30 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05491694 2022-08-08

HIFU

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05483439 2022-08-05

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

100 enrolled

Breast Neoplasms

NCT02562365 2022-07-27

ACTS

130 enrolled

Gynecologic

Ovarian Neoplasms

NCT05400993 2022-06-06

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

59 enrolled

Breast Neoplasms

NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Phase 3 Unknown

214 enrolled

Gynecologic

Gestational Trophoblastic Disease

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

24 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT00075387 2022-05-03

Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

48 enrolled

CNS

Glioma

NCT05322733 2022-04-19

Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL

25 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05302336 2022-04-14

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Phase 4 Unknown

402 enrolled

Breast Neoplasms

NCT05287984 2022-03-31

ZFCR/ZBR

63 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05147493 2022-03-29

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

51 enrolled